Source:http://linkedlifedata.com/resource/pubmed/id/21504646
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-4-20
|
pubmed:abstractText |
Prostate cancer is the second most common cause of cancer death in American men. For patients with adverse pathologic features, postoperative radiotherapy to prostate bed after radical prostatectomy has been shown in randomized studies to improve many important clinical endpoints including overall survival. In this review article, we distinguish adjuvant radiation treatment (ART) from salvage radiation treatment (SRT), discuss the evidences for ART and its potential side effects focusing on the debate concerning the optimal timing of post prostatectomy radiation treatment (RT).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1195-9479
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5592-600
|
pubmed:meshHeading |
pubmed-meshheading:21504646-Adenocarcinoma,
pubmed-meshheading:21504646-Humans,
pubmed-meshheading:21504646-Male,
pubmed-meshheading:21504646-Prostate-Specific Antigen,
pubmed-meshheading:21504646-Prostatectomy,
pubmed-meshheading:21504646-Prostatic Neoplasms,
pubmed-meshheading:21504646-Radiotherapy, Adjuvant,
pubmed-meshheading:21504646-Salvage Therapy,
pubmed-meshheading:21504646-Survival Analysis
|
pubmed:year |
2011
|
pubmed:articleTitle |
Adjuvant radiation treatment after prostatectomy. Where do we stand?
|
pubmed:affiliation |
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA.
|
pubmed:publicationType |
Journal Article,
Review
|